Sara Piemonte
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study.
Journal: Endocrine
Published: May 28, 2020
Update on vitamin D: pros and cons.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases
Published: January 27, 2016
The diagnosis and management of hypercalcaemia.
Journal: BMJ (Clinical research ed.)
Published: June 04, 2015
Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 04, 2015
Emerging data on cardiovascular risk in primary hyperparathyroidism.
Journal: Endocrine
Published: August 19, 2014
Vitamin D: not all is bad.
Journal: Journal of endocrinological investigation
Published: July 28, 2014
Vitamin D: is evidence of absence, absence of evidence?
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: July 25, 2014
Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study.
Journal: European journal of endocrinology
Published: July 13, 2014
Acute effect of zoledronic acid on the risk of cardiac dysrhythmias.
Journal: Internal and emergency medicine
Published: June 10, 2014
Effect of risedronate in osteoporotic HIV males, according to gonadal status: a pilot study.
Journal: Endocrine
Published: April 19, 2014
Osteoprotegerin serum levels in primary hyperparathyroidism and changes following surgery.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: January 14, 2014
Quality of life in patients with primary hyperparathyroidism.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: January 09, 2014
Last Updated: 09/26/2026